Low-dose gamma-irradiation inhibits il-6 secretion from human lung fibroblasts that promotes bronchial epithelial cell transformation by cigarette-smoke carcinogen

Carcinogenesis

Volumn 33, Issue 7, 2012, Pages 1368-1374

  Chen, Wenshu ^a   Xu, Xiuling ^a   Bai, Lang ^a   Padilla, Mabel T ^a   Gott, Katherine M ^a   Leng, Shuguang ^a   Tellez, Carmen S ^a   Wilder, Julie A ^a   Belinsky, Steven A ^a   Scott, Bobby R ^a   Lin, Yong ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CXCL1 CHEMOKINE; DIHYDROXYBENZO[A]PYRENE OXIDE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; STAT3 PROTEIN;

ARTICLE; BRONCHUS MUCOSA; CELL TRANSFORMATION; CIGARETTE SMOKING; COLONY FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CARCINOGENESIS; LUNG FIBROBLAST; PRIORITY JOURNAL; RADIATION DOSE; SIGNAL TRANSDUCTION; STROMA CELL;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; BRONCHI; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; DOSE-RESPONSE RELATIONSHIP, RADIATION; EPITHELIAL CELLS; FIBROBLASTS; GAMMA RAYS; HUMANS; INTERLEUKIN-6; LUNG; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; SMOKE; TOBACCO;

EID: 84865188332     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs159     Document Type: Article

References (40)

1. Dauer,L.T. et al. (2010) Review and evaluation of updated research on the health effects associated with low-dose ionising radiation. Radiat. Prot. Dosimetry, 140, 103-136.
2. Mullenders,L. et al. (2009) Assessing cancer risks of low-dose radiation. Nat. Rev. Cancer, 9, 596-604.
3. Tapio,S. et al. (2007) Radioadaptive response revisited. Radiat. Environ. Biophys., 46, 1-12.
4. Averbeck,D. (2009) Does scientific evidence support a change from the LNT model for low-dose radiation risk extrapolation? Health Phys., 97, 493-504.
5. Charles,M.W. (2006) LNT-an apparent rather than a real controversy? J. Radiol. Prot., 26, 325-329.
6. Vaiserman,A.M. (2010) Radiation hormesis: historical perspective and implications for low-dose cancer risk assessment. Dose Response, 8, 172-191.
7. Aberle,D.R. et al. (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med., 365, 395-409.
8. Tlsty,T.D. et al. (2006) Tumor stroma and regulation of cancer development. Annu. Rev. Pathol., 1, 119-150.
9. O'Callaghan,D.S. et al. (2010) The role of inflammation in the pathogenesis of non-small cell lung cancer. J. Thorac. Oncol., 5, 2024-2036.
10. Adcock,I.M. et al. (2011) Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration, 81, 265-284.
11. Yao,H. et al. (2009) Current concepts on the role of inflammation in COPD and lung cancer. Curr. Opin. Pharmacol., 9, 375-383.
12. Dougan,M. et al. (2011) A dual role for the immune response in a mouse model of inflammation-associated lung cancer. J. Clin. Invest., 121, 2436-2446.
13. Ochoa,C.E. et al. (2011) Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis. Cancer Prev. Res. (Phila.), 4, 51-64.
14. Naugler,W.E. et al. (2008) The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol. Med., 14, 109-119.
15. Karamouzis,M.V. et al. (2007) The role of STATs in lung carcinogenesis: an emerging target for novel therapeutics. J. Mol. Med. (Berl.), 85, 427-436.
16. Allen,M. et al. (2011) Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J. Pathol., 223, 162-176.
17. Kalluri,R. et al. (2006) Fibroblasts in cancer. Nat. Rev. Cancer, 6, 392-401.
18. Papadopoulou,A. et al. (2011) Human lung fibroblasts prematurely senescent after exposure to ionizing radiation enhance the growth of malignant lung epithelial cells in vitro and in vivo. Int. J. Oncol., 39, 989-999.
19. Tsai,K.K. et al. (2009) Low-dose radiation-induced senescent stromal fibroblasts render nearby breast cancer cells radioresistant. Radiat. Res., 172, 306-313.
20. Chen,W. et al. (2011) NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target. Front. Biosci., 16, 1172-1185.
21. Yu,H. et al. (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer, 9, 798-809.
22. Karin,M. (2006) Nuclear factor-kappaB in cancer development and progression. Nature, 441, 431-436.
23. Ramirez,R.D. et al. (2004) Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res., 64, 9027-9034.
24. Okamoto,M. et al. (1995) Enhancement of transformation in vitro of a nontumorigenic rat urothelial cell line by interleukin 6. Cancer Res., 55, 4581-4585.
25. Belitskaya-Levy,I. et al. (2007) Gene profiling of normal human bronchial epithelial cells in response to asbestos and benzo(a)pyrene diol epoxide (BPDE). J. Environ. Pathol. Toxico. Oncol., 26, 281-294.
26. Dreij,K. et al. (2010) Benzo[a]pyrene diol epoxide stimulates an inflammatory response in normal human lung fibroblasts through a p53 and JNK mediated pathway. Carcinogenesis, 31, 1149-1157.
27. Grivennikov, S.I. et al. (2011) Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann. Rheum. Dis., 70 (suppl. 1), i104-i108.
28. Weng,M.W. et al. (2004) Benzo[a]pyrene diol epoxide up-regulates COX-2 expression through NF-kappaB in rat astrocytes. Toxicol. Lett., 151, 345-355.
29. Huang,C. et al. (2002) Inhibition of benzo(a)pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor kappaB by black raspberry extracts. Cancer Res., 62, 6857-6863.
30. Yan,Z. et al. (2000) Benzo[a]pyrene induces the transcription of cyclooxygenase-2 in vascular smooth muscle cells. Evidence for the involvement of extracellular signal-regulated kinase and NF-kappaB. J. Biol. Chem., 275, 4949-4955.
31. Mukherjee,J.J. et al. (2009) Inhibition of benzopyrene-diol-epoxide (BPDE)-induced bax and caspase-9 by cadmium: role of mitogen activated protein kinase. Mutat. Res., 661, 41-46.
32. Lin,Y. et al. (2010) The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert. Opin. Ther. Targets, 14, 45-55.
33. Mohan,N. et al. (1994) Induction of nuclear factor kappa B after low-dose ionizing radiation involves a reactive oxygen intermediate signaling pathway. Radiat. Res., 140, 97-104.
34. Rithidech,K.N. et al. (2005) Activation of NF-kappaB in bone marrow cells of BALB/cJ mice following exposure in vivo to low doses of (137)Cs gamma-rays. Radiat. Environ. Biophys., 44, 139-143.
35. Fan,M. et al. (2007) Nuclear factor-kappaB and manganese superoxide dismutase mediate adaptive radioresistance in low-dose irradiated mouse skin epithelial cells. Cancer Res., 67, 3220-3228.
36. Shan,Y.X. et al. (2007) Ionizing radiation stimulates secretion of proinflammatory cytokines: dose-response relationship, mechanisms and implications. Radiat. Environ. Biophys., 46, 21-29.
37. Pajonk,F. et al. (2001) Ionizing radiation affects 26s proteasome function and associated molecular responses, even at low doses. Radiother. Oncol., 59, 203-212.
38. Halappanavar,S. et al. (2009) Induction of the interleukin 6/ signal transducer and activator of transcription pathway in the lungs of mice subchronically exposed to mainstream tobacco smoke. BMC Med. Genomics, 2, 56.
39. Scott,B.R. et al. (2009) Radiation-stimulated epigenetic reprogramming of adaptive-response genes in the lung: an evolutionary gift for mounting adaptive protection against lung cancer. Dose Response, 7, 104-131.
40. Sanders,C.L. et al. (2008) Smoking and hormesis as confounding factors in radiation pulmonary carcinogenesis. Dose Response, 6, 53-79.